Our Experts

Medical affairs consulting teammates conferring

Incisive Thinkers,
Decisive Leaders

Lumanity brings together a unique and diverse team of 1,100+ deeply experienced industry pioneers, data luminaries, subject matter experts, and proven problem-solvers. Meet the experts that illuminate new possibilities and help accelerate access to the treatments that transform lives.

Whitepaper Oncology Outlook for 2025

As has been true for many years, cancer remains the second leading cause of death in developed countries, and oncology remains the largest therapeutic area for biopharma R&D and sales. Accordingly, Lumanity has cultivated dedicated expertise in oncology across our businesses, including strategy consulting, medical affairs, medical communications, market insight, market access, and others. Lumanity has further established an Oncology Center of Excellence where our internal oncology experts across the company coordinate, collaborate, and share insights. As 2024 wrapped up, we reflected on some noteworthy trends and events and how they may continue to unfold and impact the field in 2025. We are pleased to share with you a collection of these perspectives.

Jan 27, 2025 Dennis Chang PhD, Jeffrey Bockman PhD, Eric Gustafson PhD, Viraj Parekh PhD, Natalie Thovmasian PhD, Michael Parisi MBA, Robert Rawlinson MA, Melissa Brunkhorst PhD

Our Experts

Ron Akehurst, Executive Chairman at Lumanity

Ron Akehurst BSc, DSc, MFPH Executive Chair, HEOR

Erin Amato MS Executive Consultant, Medical Affairs

Tom Atkinson Group Business Director, Insight

Jane Ayton Senior Vice President, Strategic Client Partnerships

Tim Barder PhD Vice President, Strategy Consulting

Sam Barnes Senior Vice President, Growth Strategy

Richard Birnie PhD Head of Advanced Analytics, HEOR

Helen Blaszczok Head of Online Communities, Insight

Jeffrey Bockman, Executive Vice President, Head of Oncology Practice at Lumanity

Jeffrey M. Bockman PhD Expert Advisor, Executive Vice President, Oncology

Naomi Boxall PhD, MVSc General Manager, The PHARMO Institute

Zoe Brown Principal, Strategy Consulting

Melissa Brunckhorst PhD Vice President, Medical Services, Communications

Podcast Medical Affairs Unscripted | Insights for Building a Rockstar MSL Team with Cathy Andorfer, PhD

Discover the secrets to building a high-performing Medical Science Liaison team and advancing your career in medical affairs as Peg Crowley-Nowick, PhD, MBA, engages in a compelling discussion with Cathy Andorfer, PhD, National Director of Field Medical at Tourmaline Bio. Gain practical insights on leadership, strategic vision, and empowering your team to drive better outcomes in the latest episode of Medical Affairs Unscripted.

Dec 4, 2024

View Illuminating the IRA: Key Questions from the First Round of MFP Negotiations

Delve into our comprehensive review of CMS's first round of maximum fair price negotiations under the Inflation Reduction Act. Uncover the answers to three critical questions about patient perspectives, therapeutic alternatives, and generic inclusion that could reshape the future of medication pricing.

Jan 21, 2025 Lauren McGuire PharmD, Leeann Lui PharmD